Showing results (41-50 of 196) with videos related to
Sort By:
Pageof 20
Food and Drug Law Journal|March 20, 2014
Structural precaution: the application of premarket approval schemes in EU food legislationBernd M J van der Meulen, Harry J Bremmers, Jo H M Wijnands, et al.Food and Drug Law Journal|March 20, 2014
The critical path from pump to pancreas: the impact of FDA regulation on the development of a closed-loop diabetes management systemRachel M SanchezFood and Drug Law Journal|March 20, 2014
New governance: can user-promulgated certification schemes provide safer, higher quality food?Tacy Katherine HassFood and Drug Law Journal|January 31, 2014
Personalized medicine and rescuing "unsafe" drugs with pharmacogenomics: a regulatory perspectiveMatthew AveryFood and Drug Law Journal|February 2, 2016
Comprehensive Legislative Reform to Protect the Integrity of the 340B Drug Discount ProgramLowell M ZetaFood and Drug Law Journal|February 2, 2016
Closing the Door to Lost Earnings Under the National Childhood Vaccine Injury Act of 1986Aaron LevinFood and Drug Law Journal|August 26, 2015
The Limits of FDA's Authority to Regulate Clinical Research Involving High-Throughput DNA SequencingBarbara J EvansFood and Drug Law Journal|August 26, 2015
Revising the Regulation of Stem Cell-Based Therapies: Critical Assessment of Potential ModelsBarbara von TigerstromFood and Drug Law Journal|August 22, 2015
Embracing 21st Century Information Sharing: Defining a New Paradigm for the Food and Drug Administration's Regulation of Biopharmaceutical Company Communications with Healthcare ProfessionalsJames M Spears, Jeffrey K Francer, Natale A TurnerFood and Drug Law Journal|October 9, 2018
When the Alpha is the Omega: P-Values, "Substantial Evidence," and the 0.05 Standard at FDALee Kennedy-ShafferPageof 20